by Jennifer P | Mar 12, 2021 | Canadian Regulatory, Cosmetics, Natural Health Products, OTC Drugs
Health Canada has announced that there will be updates to the approach to regulating self-care products as part of their 2020-2022 Forward Regulatory Plan. The self-care framework will roll out in phases over the coming years: Phase I – Target Spring 2021 will include...
by Jennifer P | Mar 12, 2021 | Canadian Regulatory, Cosmetics, U.S. Regulatory
The international nomenclature for hydrocarbon ingredients currently designated by INCI names containing the stem terms ‘isoparaffin’ and ‘pareth’ will be revised. ‘Isoalkane’ and ‘alketh’ will replace these terms, respectively, preceded by the appropriate carbon...
by Jennifer P | Mar 7, 2021 | Canadian Regulatory, Medical Devices, OTC Drugs
IO No. 2 repeals and replaces the Interim Order Respecting Drugs, Medical Devices and Foods for a Special Dietary Purpose in relation to COVID-19 (IO No. 1) made by the Minister on March 30, 2020 and approved by the Governor in Council (GIC) on April 8, 2020. It...
by Emily C | May 12, 2020 | Canadian Regulatory, OTC Drugs, Research/Science/Technology, U.S. Regulatory, Uncategorized
Recently, Health Canada announced that the Regulatory Enrolment Process (REP) will be mandatory to use as of October 1, 2020. The Health Products and Food Branch (HPFB) will be implementing this single window for transmission of regulatory transactions in electronic...
by Emily C | Apr 3, 2020 | Canadian Regulatory, Innovation, Medical Devices, Research/Science/Technology, U.S. Regulatory
Recently, information has been provided regarding updates that Health Canada and the U.S. FDA have done in order to aid in the battle against COVID-19. However, other countries have also taken drastic measures to assist with reducing the spread of COVID-19. The...
Recent Comments